Correlation Between Eliem Therapeutics and Mineralys Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and Mineralys Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and Mineralys Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and Mineralys Therapeutics, Common, you can compare the effects of market volatilities on Eliem Therapeutics and Mineralys Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of Mineralys Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and Mineralys Therapeutics,.
Diversification Opportunities for Eliem Therapeutics and Mineralys Therapeutics,
-0.56 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Eliem and Mineralys is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and Mineralys Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mineralys Therapeutics, and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with Mineralys Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mineralys Therapeutics, has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and Mineralys Therapeutics, go up and down completely randomly.
Pair Corralation between Eliem Therapeutics and Mineralys Therapeutics,
Given the investment horizon of 90 days Eliem Therapeutics is expected to under-perform the Mineralys Therapeutics,. But the stock apears to be less risky and, when comparing its historical volatility, Eliem Therapeutics is 1.12 times less risky than Mineralys Therapeutics,. The stock trades about -0.29 of its potential returns per unit of risk. The Mineralys Therapeutics, Common is currently generating about -0.05 of returns per unit of risk over similar time horizon. If you would invest 1,389 in Mineralys Therapeutics, Common on August 28, 2024 and sell it today you would lose (119.00) from holding Mineralys Therapeutics, Common or give up 8.57% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 95.24% |
| Values | Daily Returns |
Eliem Therapeutics vs. Mineralys Therapeutics, Common
Performance |
| Timeline |
| Eliem Therapeutics |
| Mineralys Therapeutics, |
Eliem Therapeutics and Mineralys Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eliem Therapeutics and Mineralys Therapeutics,
The main advantage of trading using opposite Eliem Therapeutics and Mineralys Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, Mineralys Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mineralys Therapeutics, will offset losses from the drop in Mineralys Therapeutics,'s long position.| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
| Mineralys Therapeutics, vs. Eliem Therapeutics | Mineralys Therapeutics, vs. HCW Biologics | Mineralys Therapeutics, vs. Scpharmaceuticals | Mineralys Therapeutics, vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |